A 3-week, open label study to evaluate the efficacy and safety of extended release quetiapine fumarate in the treatment of agitation in patients with schizophrenia
Objective: To evaluate the efficacy of extended-release quetiapine fumarate (XR) monotherapy once daily, in the treatment of patients with acute episodes of schizophrenia and agitation. Method: Our study was a 3-week open-label study conducted in adult in- or outpatients with schizophrenia. Quetiapi...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/10973/1/A_3-week%2C_open_label_study_to_evaluate_the_efficacy.pdf http://eprints.um.edu.my/10973/ http://www.psikofarmakoloji.org/pdf/23_1_4.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|